Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Main Authors: | Church, D, Midgley, R, Kerr, D |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2012
|
פריטים דומים
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
מאת: Midgley, R, et al.
יצא לאור: (2005) -
The emergence of 'omics for the management of colorectal cancer.
מאת: Midgley, R, et al.
יצא לאור: (2011) -
Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?
מאת: Chan TY, et al.
יצא לאור: (2017-03-01) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
מאת: Midgley, R, et al.
יצא לאור: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
מאת: Joao Paulo Solar Vasconcelos, et al.
יצא לאור: (2022-12-01)